Abstract

Congenital hypogonadotropic hypogonadism/Kallmann syndrome (CHH/KS) is a rare, treatable form of infertility. Like other rare disease patients, individuals with CHH/KS frequently experience feelings of isolation, shame, and alienation. Unlike many rare diseases, CHH/KS is not life threatening and effective treatments are available. Nevertheless, it remains a profoundly life-altering condition with psychosocial distress on a par with untreatable or life-limiting disease. Patients with CHH/KS frequently express lasting adverse psychological, emotional, social, and psychosexual effects resulting from disrupted puberty. They also frequently experience a “diagnostic odyssey,” characterized by distressing and convoluted medical referral pathways, lack-of-information, misinformation, and sometimes-incorrect diagnoses. Unnecessary delays in diagnosis and treatment-initiation can significantly contribute to poor body image and self-esteem. Such experiences can erode confidence and trust in medical professionals as well as undermine long-term adherence to treatment–with negative sequelae on health and wellbeing. This review provides a summary of the psychological aspects of CHH/KS and outlines an approach to comprehensive care that spans medical management as well as appropriate attention, care and referrals to peer-to-peer support and mental health services to ameliorate the psychological aspects of CHH/KS.

Highlights

  • Congenital hypogonadotropic hypogonadism (CHH) is a rare genetic endocrine disorder causes by the insufficient secretion or action of gonadotropin-releasing hormone (GnRH)

  • Box 2 | Red flags pointing to Congenital hypogonadotropic hypogonadism/Kallmann syndrome (CHH/Kallmann syndrome (KS)) diagnosis

  • This point is relevant because breast size and appearance can be a source of significant anxiety and may impair body image for many eugonadal women–let alone those women with CHH/KS

Read more

Summary

Psychological Aspects of Congenital Hypogonadotropic Hypogonadism

Reviewed by: Ludwig Wildt, Innsbruck Medical University, Austria Himanshu Arora, University of Miami, United States. CHH/KS is not life threatening and effective treatments are available. Patients with CHH/KS frequently express lasting adverse psychological, emotional, social, and psychosexual effects resulting from disrupted puberty. They frequently experience a “diagnostic odyssey,” characterized by distressing and convoluted medical referral pathways, lack-of-information, misinformation, and sometimes-incorrect diagnoses. Unnecessary delays in diagnosis and treatment-initiation can significantly contribute to poor body image and self-esteem. Such experiences can erode confidence and trust in medical professionals as well as undermine long-term adherence to treatment–with negative sequelae on health and wellbeing.

INTRODUCTION
Psychological Aspects
THE CHALLENGE OF DIAGNOSIS
MISCONCEPTIONS REGARDING TREATMENT
CHALLENGES FACED BY PATIENTS
TARGETS FOR IMPROVING CARE
FUTURE DIRECTIONS
Findings
CONCLUSIONS
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call